Innovation America Innovation America Accelerating the growth of the GLOBAL entrepreneurial innovation economy
Founded by Rich Bendis

money

Venture capital-backed initial public offerings more than doubled during the second quarter from the previous quarter and rose 90% from a year earlier, with 21 companies raising a combined $2.2 billion during their stock-market debuts, driven by the highest number of biotech venture-backed IPOs in nearly 13 years, according to Thomson Reuters Corp. (TRI, TRI.T) and the National Venture Capital Association.

During the quarter, 13 of the offerings were in the life-sciences sector, representing 62% of the total. Biotech offerings, at 11 deals, marked the highest level since the third quarter of 2000, when 13 companies went public.

To read the original article: Venture-Capital-Backed IPOs Surge in Second Quarter, Led by Biotech Offerings - WSJ.com